Rantamäki M, Luoma P, Virta J J, Rinne J O, Paetau A, Suomalainen A, Udd B
Department of Physical Medicine and Rehabilitation, Seinäjoki Central Hospital, Seinäjoki, Finland.
Clin Genet. 2007 Dec;72(6):532-7. doi: 10.1111/j.1399-0004.2007.00908.x. Epub 2007 Sep 25.
Mitochondrial recessive ataxia syndrome (MIRAS) is a common cause of autosomal recessive juvenile- or adult-onset ataxia, at least in Scandinavia. MIRAS patients are homozygous or compound heterozygous for POLG mutations W748S and A467T. Because many first-degree relatives of MIRAS patients in the studied families have reported neurological symptoms and some recent studies have suggested dominant negative effect of these mutations, a careful family study of heterozygotes was needed. We investigated all available members of the original large MIRAS family with W748S mutation. Neurological symptoms and signs were present in a number of carriers, but clearly defined neurological diseases did not segregate consistently with the mutation. Sensory polyneuropathy as a subclinical finding was observed in the majority of carriers examined. By positron emission tomography, cerebral glucose metabolism was moderately reduced in two out of four heterozygotes compared with severe reduction in one MIRAS patient. In conclusion, W748S heterozygotes showed no clinically manifesting phenotype.
线粒体隐性共济失调综合征(MIRAS)是常染色体隐性青少年或成人期共济失调的常见病因,至少在斯堪的纳维亚地区如此。MIRAS患者对于POLG基因的W748S和A467T突变而言为纯合子或复合杂合子。由于在研究的家族中,许多MIRAS患者的一级亲属都报告有神经症状,且最近的一些研究表明这些突变具有显性负效应,因此需要对杂合子进行仔细的家族研究。我们调查了最初携带W748S突变的大型MIRAS家族的所有在世成员。许多携带者都有神经症状和体征,但明确的神经疾病并未与该突变一致地分离。在大多数接受检查的携带者中观察到感觉性多发性神经病这一亚临床发现。通过正电子发射断层扫描,与一名MIRAS患者的严重脑葡萄糖代谢降低相比,四名杂合子中有两名的脑葡萄糖代谢中度降低。总之,W748S杂合子未表现出临床显性表型。